Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate advances two‑part CBD bill: product testing/registration and DEA waiver push for pharmacy dispensing
Summary
The Senate passed a second substitute for a bill that (1) creates a registration and testing regime for hemp‑grade CBD products to protect consumers and (2) seeks a DEA waiver to allow medical‑grade CBD to move from physician prescription to pharmacy dispensing under controlled conditions.
The Utah Senate moved a two‑component bill forward that sponsors described as a narrow, public‑safety approach to hemp‑derived cannabidiol (CBD).
Sponsor remarks explained the bill has two parts. First, the Department of Agriculture would register manufacturers selling hemp‑grade CBD in Utah and collect fees to fund product testing to ensure products are actually hemp‑grade and are not laced with contaminants. "The first part of the bill simply sets up a process where the Department of Ag can…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
